PUBLISHER: Inkwood Research | PRODUCT CODE: 1063736
PUBLISHER: Inkwood Research | PRODUCT CODE: 1063736
The Europe amniotic membrane market is projected to register a CAGR of 6.92% during the forecast period, 2022-2030. The rising applications in oral surgery and ophthalmology and the growing geriatric population are the key drivers of market growth.
Italy, Russia, Belgium, Poland, Germany, France, the United Kingdom, and Rest of Europe are analyzed for the Europe amniotic membrane market growth assessment. Germany has a large number of healthcare facilities and hospitals that facilitate AM (amniotic membrane) treatment. Also, tissue donation is encouraged in the country. For instance, the Germany Society for Tissue Transplantation organizes nationwide tissue donation and offers bone grafts, blood vessels, heart valves, amniotic tissue, and corneal transplants.
Further, AM tissue transplants are part of the standard medical care in Germany. In addition, German doctors have transplanted hundreds of bone preparations and cardiovascular tissues and almost 60,000 corneas. In Italy, AM tissue donations increased between 2013 and 2020. As a result, it is an emerging market for AM use. Additionally, AM use is on the rise in wound care, ophthalmology, and dermatology, alongside various institutes conducting research on the same for the last 12 years.
Further, in Russia, the market growth is driven by the growing number of surgeries, the rising disease awareness, and the increasing R&D investments in stem cell and regenerative medicine fields. At the same time, the lack of stringent regulations and awareness are expected to affect the market growth.
Some of the prominent market players are: Labtician Ophthalmics Inc, Integra LifeSciences Corp, Stryker Corporation, Amniox Medical Inc, Celularity Inc, etc.